Brief: Bioventus Q1 Adjusted EPS USD 0.07
07/05/2024 12:00
May 07 (Reuters) - Bioventus Q1 adjusted EBITDA USD 22.6 million. * Q1 sales USD 129.5 million * outlook FY sales USD 535-550 million
Recent news on Bioventus
See all newsBioventus Inc. reports results for the quarter ended June 30 - Earnings Summary
Bioventus Q2 revenue misses estimates on surgical solutions decline
Bioventus Inc expected to post earnings of 22 cents a share - Earnings Preview
Bioventus Q1 revenue rises 7%, beats expectations
U.S. STOCKS ON THE MOVE -Erasca Inc, Regenxbio, Natgas stocks